Commentary on "Exome sequencing and electro-clinical features in pediatric patients with very early-onset retinal dystrophies: A cohort study"

Affiliations

¹ Jonas Children's Vision Care, Department of Ophthalmology, New York-Presbyterian Hospital, New York, NY, USA.
² Jonas Children's Vision Care, Department of Ophthalmology, New York-Presbyterian Hospital, New York, NY, USA; Department of Pathology & Cell Biology, Institute of Human Nutrition, and Columbia Stem Cell Initiative, New York, NY, USA. Electronic address: sht2@cumc.columbia.edu.

Editorial

Kimia Heydari et al. Eur J Paediatr Neurol. 2021 Mar.

. 2021 Mar:31:106-107.

doi: 10.1016/j.ejpn.2021.03.004. Epub 2021 Mar 8.

¹ Jonas Children's Vision Care, Department of Ophthalmology, New York-Presbyterian Hospital, New York, NY, USA.
² Jonas Children's Vision Care, Department of Ophthalmology, New York-Presbyterian Hospital, New York, NY, USA; Department of Pathology & Cell Biology, Institute of Human Nutrition, and Columbia Stem Cell Initiative, New York, NY, USA. Electronic address: sht2@cumc.columbia.edu.

No abstract available

Conflict of interest statement

Declaration of competing interest SHT was a consultant for Spark Therapeutics and received research funding from Abeona Therapeutics, Inc.

Exome sequencing and electro-clinical features in pediatric patients with very early-onset retinal dystrophies: A cohort study.
Suppiej A, Ceccato C, Maritan V, Cermakova I, Colavito D, Leon A. Suppiej A, et al. Eur J Paediatr Neurol. 2021 Mar;31:1-9. doi: 10.1016/j.ejpn.2021.01.003. Epub 2021 Jan 22. Eur J Paediatr Neurol. 2021. PMID: 33529788